CYP3A Polymorphism and Chronic Mercury Intoxication

被引:3
|
作者
Chernyak, Yu. I. [1 ]
Merinova, A. P. [1 ]
机构
[1] East Siberian Inst Med & Ecol Res, Angarsk, Russia
关键词
mercury; chronic mercury intoxication; cytochrome P4503A (CYP3A); genetic polymorphism; antipyrine metabolism; METHYLMERCURY; METABOLISM; GENES;
D O I
10.1007/s10517-020-04738-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We analyzed the relationship between polymorphic loci of CYP3A genes (CYP3A4 (rs2740574), CYP3A5 (rs776746) and CYP3A7 (rs2257401)) with the development of chronic mercury intoxication. Of 170 men examined, 120 were workers chronically exposed to mercury vapors and 50 were carriers of GG-HSPA1B (+1267A/G) genotype associated with chronic mercury intoxication. Urinary content of 4-hydroxyantipyrine (4-HAP) generated in the reaction predominantly catalyzed by CYP3A4/CYP3A5 was studied in workers without chronic mercury intoxication (group 1, N=46) and patients in the delayed period of chronic mercury intoxication (group 2, N=74) depending on the genotypes of CYP3A4 and CYP3A5. For polymorphic loci CYP3A5 and CYP3A7, a tendency to an increase in the frequency of genotypes with rare alleles was found (p=0.071 and p=0.078) in the combined group (group 2 together with GGHSPA1B genotype carriers) relative to group 1. The high level of linkage disequilibrium was noted, especially for the pair rs776746 and rs2257401 (LD (r)=0.89). In group 2, a trend to 4-HAP decrease compared to group 1 (p=0.056 and p=0.065) was revealed for carriers of AA-CYP3A4 and GG-CYP3A5 genotypes. The involvement of CYP3A in the development of mercury neurotoxic effect remains unclear.
引用
收藏
页码:492 / 495
页数:4
相关论文
共 50 条
  • [31] CYP3A genetics in drug metabolism
    Michel Eichelbaum
    Oliver Burk
    Nature Medicine, 2001, 7 : 285 - 287
  • [32] Clinical implications of CYP3A polymorphisms
    Wojnowski, Leszek
    Kamdem, Landry K.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (02) : 171 - 182
  • [33] The Role of CYP3A in Health and Disease
    Klyushova, Lyubov S.
    Perepechaeva, Maria L.
    Grishanova, Alevtina Y.
    BIOMEDICINES, 2022, 10 (11)
  • [34] A comparative study for detecting CYP3A induction by CYP3A probe drugs and endogenous markers in cynomolgus monkeys
    Tahara, Harunobu
    Watanabe, Miwa
    Hasegawa, Maki
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2019, 40 (02) : 81 - 93
  • [35] IMMUNOPATHOGENETIC PROCESSES IN CHRONIC MERCURY INTOXICATION
    Ferapontova, E. V.
    Fedotkina, L. K.
    Novikova, L. V.
    MORDOVIA UNIVERSITY BULLETIN, 2006, 2 : 191 - 196
  • [36] Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail
    Lee, Eunyoung
    Shon, Jong Cheol
    Liu, Kwang-Hyeon
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (06) : 366 - 372
  • [37] The Effects on Metabolic Clearance when Administering a Potent CYP3A Autoinducer with the Prototypic CYP3A Inhibitor, Ketoconazole
    Ayan-Oshodi, Mosun A.
    Willis, Brian A.
    Annes, William F.
    Lowe, Stephen L.
    Friedrich, Stuart
    de la Pena, Amparo
    Zhang, Wei
    Brown, Thomas
    Wise, Stephen D.
    Hall, Stephen D.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (10) : 1945 - 1952
  • [38] Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity
    Hafner, V.
    Jaeger, M.
    Matthee, A-K
    Ding, R.
    Burhenne, J.
    Haefeli, W. E.
    Mikus, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (02) : 191 - 196
  • [39] CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients
    Wei Zhang
    Yan-Zi Chang
    Quan-Cheng Kan
    Li-Rong Zhang
    Zhi-Song Li
    Hui Lu
    Zhong-Yu Wang
    Qin-Jun Chu
    Jie Zhang
    European Journal of Clinical Pharmacology, 2010, 66 : 61 - 66
  • [40] CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients
    Zhang, Wei
    Chang, Yan-Zi
    Kan, Quan-Cheng
    Zhang, Li-Rong
    Li, Zhi-Song
    Lu, Hui
    Wang, Zhong-Yu
    Chu, Qin-Jun
    Zhang, Jie
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (01) : 61 - 66